ValiRx plc (AIM: VAL)
Health Care · Biotechnology · GB
£0.00
+8.00% today · -74.3% 1Y
ValiRx plc (AIM: VAL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.36M.
Over the last twelve months the share price has lost 74.3%, trading between 0.00 and 0.01.
Tweenvest scores ValiRx plc across four factors: quality 37/100, value 40/100. Its strongest factor is value.
VAL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.36M
- Revenue (TTM)
- $43.35K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -0.24
- 52-week high
- £0.01
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.32B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Matinas BioPharma Holdings, Inc.NYSEAM: MTNB | $2.59M | $2.76 | +4.55% |
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $2.58M | $0.41 | -37.87% |
| Enzolytics, Inc.OTCPK: ENZC | $2.42M | $0.00 | +25.00% |
| CASI Pharmaceuticals, Inc.OTCPK: CASI.F | $2.41M | $0.12 | -9.16% |
| International Stem Cell CorporationOTCPK: ISCO | $2.32M | $0.29 | -16.08% |
| Oncology Pharma Inc.OTCPK: ONPH | $2.32M | $0.06 | +50.00% |
| Silo Pharma, Inc.NasdaqCM: SILO | $2.32M | $1.41 | -3.29% |
| Valion Bio, Inc.NasdaqCM: VBIO | $2.30M | $2.22 | -14.29% |
Figures last refreshed Oct 4, 2026.